BACTERIAL DELIVERY SYSTEMS FOR IMMUNOGENIC PROTEINS: CURRENT ADVANCES, LIMITATIONS AND CHALLENGES

Km Himani

doi:10.56093/ijvasr.v55i5.183310

Authors

Km Himani Assistant Professor, Department of Veterinary Clinical Complex, Arawali Veterinary College, Sikar, Rajasthan Universtiy of Veterinary and Animal Sciences, Bikaner, Rajasthan - 332 403

https://doi.org/10.56093/ijvasr.v55i5.183310

Keywords:

Bacterial delivery systems, antigen delivery, outer membrane vesicles, bacterial ghosts, vaccine engineering

Abstract

Bacterial platforms are emerging as versatile systems for delivering heterologous antigens and therapeutic proteins, driven by advances in microbial engineering and insights into host–pathogen interactions. This review summarizes recent peer-reviewed literature on bacterial delivery platforms, focusing on their mechanisms, immunological properties, applications, and limitations. Major approaches including live attenuated bacteria, secretion systems, surface display technologies, spores, outer membrane vesicles (OMVs), and bacterial ghosts (BGs) enable targeted intracellular or mucosal delivery and can elicit strong humoral, cellular, and innate immune responses. Live vectors naturally target antigen-presenting cells, while secretion systems such as the Type III secretion system (T3SS) allow precise cytosolic delivery. Spores provide stable, low-cost vehicles, and OMVs and BGs offer non-replicating particulate platforms with intrinsic adjuvanticity. Despite their potential, each system faces limitations, including low immunogenicity (spores), LPS toxicity and variability (OMVs, BGs), biosafety concerns (live vectors), and size or folding constraints (secretion and surface-display systems). Advancements in synthetic biology, immunomodulation, and scalable manufacturing are needed to overcome these barriers. Collectively, bacterial delivery platforms hold significant promise for next-generation vaccines and therapeutic protein delivery.

Downloads

Download data is not yet available.

References

Akeda, Y. and Galán, J.E. (2005). Chaperone release and unfolding of substrates in type III secretion. Nature, 437: 911–915.

Andrade, A., Pablo, J., Espinosa, N., Pe, G. and Gonza, B. (2007). Enzymatic characterization of the enteropathogenic Escherichia coli type III secretion ATPase EscN. Archives of Biochemistry and Biophysics, 468: 121–127.

Bansal, G., Ghanem, M., Sears, K.T., Galen, J.E. and Tennant, S.M. (2024). Genetic engineering of Salmonella spp. for novel vaccine strategies and therapeutics. EcoSal Plus, 12(1): eesp00042023

Buttner, D. (2012). Protein export according to schedule: architecture, assembly, and regulation of type III secretion systems from plant- and animal- pathogenic bacteria. Microbiology and Molecular Biology Reviews, 76:262–310.

Cai, K., Tu, W. and Liu, Y. (2015). Novel fusion antigen displayed-bacterial ghosts vaccine candidate against infection of Escherichia coli O157:H7. Scientific Reports, 5:17479.

Chakameh, A.T., Petra, B.W., Ulrike, M., Thomas, S., Matthias, B., John, M.C. and Werner, L. (2004). Bacterial ghosts-biological particles as delivery systems for antigens nucleic acids and drugs. Frontiers in Microbiology, 15: 445.

Chen, P. and Goldberg, M.B. (2023). Recent insights into type 3 secretion system injectisome structure and mechanism of human enteric pathogens. Current Opinion in Microbiology, 71: 102232.

Cornelis, G.R. and Wolfwatz, H. (1997). The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells. Molecular Microbiology, 23(5): 861-867.

Cortes-Perez, N.G., Lefèvre, F., Corthier,G., Adel-Patient, K., Langella, P. and Bermúdez-Humarán, L.G. (2007) Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria. Vaccine, 25: 6581-6588.

Dey, S. and Sankaran, S. (2024). Engineered bacterial therapeutics with material solutions. Trends Biotechnology, 42(12): 1663-1676.

Duc, l.H., Hong, H.A., Fairweather, N., Ricca, E. and Cutting, S.M. (2003) Bacterial spores as vaccine vehicles. Infection and Immunity, 71: 2810-2818.

Frahm, M., Felgner, S., Kocijancic, D., Rohde, M., Hensel, M., Rd, C.R., Erhardt, M. and Weiss, S. (2015). Efficiency of conditionally attenuated Salmonella enterica serovar Typhimurium in bacterium-mediated tumor therapy. Mbio, 6(2): 55-59.

Ganglberger, E., Barbara, S., Scholl, I., Wiedermann, U., Baumann, S., Hafner, C., et al. (2001). Monovalent fusion proteins of IgE mimotopes are safe for therapy of type I allergy. FASEB J.15: 2524–2526.

Henrich, B., Lubitz, W. and Plapp, R. (1982). Lysis of Escherichia coli by induction of cloned phi X174 genes. Molecular Genetics and Genomics, 185: 493–497.

Hu, C.M., Fang, R.H., Wang, K.C., Luk, B.T., Thamphiwatana, S., Dehaini, D., Nguyen, P., Angsantikul, P., Wen, C.H., Kroll, A.V., Carpenter, C., Ramesh, M., Qu, V., Patel, S.H., Zhu, J., Shi, W., Hofman, F.M., Chen, T.C., Gao, W., Zhang, K., Chien, S. and Zhang, L. (2015). Nanoparticle biointerfacing by platelet membrane cloaking. Nature, 526: 118–121.

Ilk, N., Schumi, C.T., Bohle, B., Egelseer, E.M. and Sleytr, U.B. (2011). Expression of an endotoxin-free S-layer/allergen fusion protein in gram-positive Bacillus subtilis 1012 for the potential application as vaccines for immunotherapy of atopic allergy. Microbial Cell Factories, 10:6.

Ittig, S.J., Schmutz, C., Kasper, C.A., Amstutz, M., Schmidt, A., Sauteur, L., Vigano, M.A., Low, S.H., Affolter, M. and Cornelis, G.R. (2015). A bacterial type III secretion-based protein delivery tool for broad applications in cell biology. Journal of Cell Biology, 211(4): 913-931.

Jager, J., Marwitz, S., Tiefenau, J., Rasch, J., Shevchuk, O., Kugler, C., Goldmann, T. and Steinert, M. (2014). Human lung tissue explants reveal novel interactions during Legionella pneumophila infections. Infection and Immunity, 82: 275–285.

Jahn-Schmid, B., Siemann, U., Zenker, A., Bohle, B., Messner, P., Unger, F.M., sleytr, U.B., Scheiner, O., Kraft, D. and Ebner, C. (1997). Bet v 1, the major birch pollen allergen, conjugated to crystalline bacterial cell surface roteins, expands allergen-specific T cells of the Th1/Th0 phenotype in vitro by induction of IL-12. International Immunology, 9: 1867–1874.

Janeway, C.A. and Medzhitov, R. (2002) Innate immune recognition. Annual Review Immunology, 20:197-216.

Jawale, C.V. and Lee, J.H. (2014). Comparative evaluation of Salmonella enteritidis ghost vaccines with a commercial vaccine for protection against internal egg contamination with Salmonella sp. Vaccine, 32: 5925–5930.

Jones, B.D., Pascopella, L. and Falkow, S. (1995). Entry of microbes into the host: Using M cells to break the mucosal barrier. Current Opinion in Immunology, 7(4), 474–478.

Juárez-Rodríguez, M.D., Yang, J., Kader, R., Alamuri, P., Roy Curtiss, I. and Clark- Curtiss, J.E. (2012). Live attenuated salmonella vaccines displaying regulated delayed lysis and delayed antigen synthesis to confer protection against Mycobacterium tuberculosis. Infection and Immunity, 80(2): 815-831.

Kaufmann, S.H. and Hess, J. (1999). Impact of intracellular location and antigen display by intracellular bacteria: implications for vaccine development. Immunology Letters, 65: 81-84.

Kim, J.H., Yoon, Y.J., Lee, J., Choi, E.J., Yi, N., Park, K.S., Park, J., Lőtvall, J., Kim, Y.K. and Gho, Y.S. (2013). Outer membrane vesicles derived from Escherichia coli up-regulate expression of endothelial cell adhesion molecules in vitro and in vivo. PLoS ONE, 8(3) : e59276.

Kimura, K., Iwatsuki, M., Nagai, T., Matsumoto, A., Takahashi, Y., Shiomi, K., Omura, S. and Abe, A. (2011). A small-molecule inhibitor of the bacterial type III secretion system protects against in vivo infection with Citrobacter rodentium. The Journal of Antibiotics (Tokyo), 64, 197–203.

Ko, S.H., Jeon, J.I., Kim, Y.J., Yoon, H.J., Kim, H., Kim, N., Kim, J.S. and Kim, J.M. (2015). Helicobacter pylori outer membrane vesicle proteins induce human eosinophil degranulation via a beta2 integrin CD11/CD18- and ICAM-1-dependent mechanism. Mediators of Inflammation, 1: 301716.

Kotton, C.N. and Hohmann, E.L. (2004) Enteric pathogens as vaccine vectors for foreign antigen delivery. Infection and Immunity, 72:5535-5547.

Kwon, S.Y., Thi-Thu Ngo, H., Son, J., Hong, Y. and Min, J.J. (2024). Exploiting bacteria for cancer immunotherapy. Nature Reviews Clinical Oncology, 21(8), 569-589.

Le Gouëllec, A., Chauchet, X., Polack, B., Buffat, L. and Toussaint, B. (2012). Bacterial vectors for active immunotherapy reach clinical and industrial stages. Human Vaccines and Immunotherapeutics, 8(10): 1454–1458.

Liu, Q., Liu, Q., Yi, J., Liang, K., Hu, B., Zhang, X., Curtiss, R. III. and Kong, Q (2016). Outer membrane vesicles from flagellin-deficient Salmonella enterica serovar typhimurium induce cross-reactive immunity and provide crossprotection against heterologous Salmonella challenge. Science Rep. 6:34776

Mayr, U.B., Walcher, P. and Azimpour, C. (2005). Bacterial ghosts as antigen delivery vehicles. Advanced Drug Delivery Reviews, 57:1381–1391.

Miao, E.A. and Miller, S.I. (2000). A conserved amino acid sequence directing intracellular type III secretion by Salmonella typhimurium. Proceedings of the National Academy of Sciences of the USA, 97: 7539–7544.

Mori, H. and Ito, K. (2001). The sec protein- translocation pathway. Trends in Microbiology, 9(10): 494-500

Munera, D., Crepin, V.F., Marches, O. and Frankel, G. (2010). N-terminal type III secretion signal of enteropathogenic Escherichia coli translocator proteins. Journal of Bacteriology, 192: 3534–3539.

Paccez, J.D., Nguyen, H.D., Luiz, W.B., Ferreira, R.C., Sbrogio-Almeida, M.E., Schuman, W. and Ferreira, L.C. (2007). Evaluation of different promoter sequences and antigen sorting signals on the immunogenicity of Bacillus subtilis vaccine vehicles. Vaccine, 25: 4671-4680.

Pais, S.V., Kim, E. and Wagner, S. (2023). Virulence-associated type III secretion systems in gram-negative bacteria. Journal of Medical Microbiology, 169(6):001328.

Panthel, K., Meinel, K.M., Sevil Domènech, V.E., Trülzsch, K. and Rüssmann, H. (2008). Salmonella type III- mediated heterologous antigen delivery: a versatile oral vaccination strategy to induce cellular immunity against infectious agents and tumors. International Journal of Medical Microbiology, 298(1 –2): 99-103.

Rescigno, M., Rotta, G., Valzasina, B. and Ricciardi-Castagnoli, P. (2001). Dendritic cells shuttle microbes across gut epithelial monolayers. Immunobiology, 204: 572-581.

Saggese, A., Baccigalupi, L., Donadio, G., Ricca, E. and Isticato, R. (2023). The bacterial spore as a mucosal vaccine delivery system. International Journal of Molecular Sciences, 24(13), 10880.

Shahid, G.B., Ahan, R.E., Ostaku, J. and Şeker, U.Ö.Ş. (2024). Bacterial living therapeutics with engineered protein secretion circuits to eliminate breast cancer cells. ACS Synthetic Biology, 13(10): 3150–3162.

Sleytr, U.B., Schuster, B., Egelseer, E.M. and Pum, D. (2014). S-layers: principles and applications. FEMS Microbiology Reviews, 38: 823–864.

Toussaint, B., Chauchet, X., Wang, Y., Polack, B. and Le, G.A. (2013). Live-attenuated bacteria as a cancer vaccine vector. Expert Review of Vaccines,12(10): 1139.

Toyofuku, M., Schild, S., Kaparakis- Liaskos, M. and Eberl, L. (2023). Composition and functions of bacterial membrane vesicles. Nature Reviews Microbiology, 21(7), 415–430.

Trülzsch, K., Roggenkamp,A., Aepfelbacher, M., Wilharm, G., Ruckdeschel, K. and Heesemann, J. (2003). Analysis of chaperone-dependent Yop secretion/ translocation and effector function using a mini-virulence plasmid of Yersinia enterocolitica. International Journal of Medical Microbiology, 293(2): 167-177.

Underhill, D.M. and Goodridge, H.S. (2012). Information processing during phagocytosis. National Reviews of Immunology, 12: 492–502.

Uyen, N.Q., Hong, H.A. and Cutting, S.M. (2007). Enhanced immunisation and expression strategies using bacterial spores as heat-stable vaccine delivery vehicles. Vaccine, 25: 356-365.

Woltjen, K., Michael, I.P., Mohseni, P., Desai, R., Mileikovsky, M., Hamalainen, R., Cowling, R., Wang, W., Liu, P., Gertsenstein, M., Kaji, K., Sung, H.K. and Nagy, A. (2009). piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature, 458(7239): 766 -770.

Worrall, L.J., Majewski, D.D. and Strynadka, N.C.J. (2023). Structural insights into type III secretion systems of the bacterial flagellum and injectisome. Annual Review of Microbiology.

Yu, X., Wang, L., Yang, X., Zhang, S., Li, G., Zhang, L., Li, J., Wang, X., Zhou, H., Jiang, Y., Cui, W., Li, Y., Tang, L. and Qiao, X. (2022). Lactobacillus casei ghosts as a vehicle for the delivery of DNA vaccines mediate immune responses. Frontiers in Immunology, 13 : 849409.

Yuan, C., Ji, X., Zhang, Y., Liu, X., Ding, L., Li, J., Ren, S., Liu, F., Chen, Z., Zhang, L., Zhu, W., Yu, J. and Wu, J. (2024). Important role of Bacillus subtilis as a probiotic and vaccine carrier in animal health maintenance. World Journal of Microbiology and Biotechnology, 40:268.

Zhang, H., Li, W., Li, Y., Wang, Y., Jin, Y., Tong, D., Li, Z. and Zhou, J. (2024). Bacterial ghosts engineered with lipidated antigens as an adjuvant-free vaccine for Chlamydia abortus. International Journal of Pharmaceutics, 666: 124801.

Zurawski, D.V. and Stein, M.A. (2003). SseA acts as the chaperone for the SseB component of the Salmonella pathogenicity island 2 translocon. Molecular Microbiology, 47: 1341–1351.